ACAD
ACADIA Pharmaceuticals Inc
Price:  
18.27 
USD
Volume:  
1,430,975.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Acadia Intrinsic Value

-42.57 %
Upside

As of 2024-11-12, the Intrinsic Value of ACADIA Pharmaceuticals Inc (ACAD) is 10.49 USD. This Acadia valuation is based on the model Peter Lynch Fair Value. With the current market price of 18.27 USD, the upside of ACADIA Pharmaceuticals Inc is -42.57%.

18.27 USD
Stock Price
10.49 USD
Intrinsic Value
Intrinsic Value Details

Acadia Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) (92.27) - (10.23) (18.54) -201.5%
DCF (Growth 10y) (12.93) - (109.38) (22.78) -224.7%
DCF (EBITDA 5y) (7.84) - (9.76) (1,234.50) -123450.0%
DCF (EBITDA 10y) (11.00) - (15.46) (1,234.50) -123450.0%
Fair Value 10.49 - 10.49 10.49 -42.57%
P/E 16.72 - 20.34 18.22 -0.2%
EV/EBITDA 14.08 - 18.99 15.77 -13.7%
EPV (8.88) - (15.80) (12.34) -167.5%
DDM - Stable 4.63 - 44.81 24.72 35.3%
DDM - Multi (2.70) - (22.40) (4.99) -127.3%

Acadia Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 3,030.63
Beta 0.85
Outstanding shares (mil) 165.88
Enterprise Value (mil) 2,875.48
Market risk premium 4.60%
Cost of Equity 10.64%
Cost of Debt 5.00%
WACC 7.80%